Expression profiles of adult T-cell leukemialymphoma and associations with clinical responses to zidovudine and interferon α

Ash A. Alizadeh, Sean P. Bohen, Chen Lossos, Jose A. Martinez-Climent, Juan Carlos Ramos, Elena Cubedo-Gil, William J. Harrington, Izidore Lossos

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Adult T-cell leukemialymphoma (ATLL) is an HTLV-1-associated lymphoproliferative malignancy that is frequently fatal. We compared gene expression profiles (GEPs) of leukemic specimens from nine patients with ATLL at the time of diagnosis and immediately after combination therapy with zidovudine (AZT) and interferon α (IFNα). GEPs were also related to genetic aberrations determined by comparative genomic hybridization. We identified several genes anomalously over-expressed in the ATLL leukemic cells at the mRNA level, including LYN, CSPG2, and LMO2, and confirmed LMO2 expression in ATLL cells at the protein level. In vivo AZTIFNα therapy evoked a marked induction of interferon-induced genes accompanied by repression of cell-cycle regulated genes, including those encoding ribosomal proteins. Remarkably, patients not responding to AZTIFNα differed most from responding patients in lower expression of these same IFN-responsive genes, as well as components of the antigen processing and presentation apparatus. Demonstration of specific gene expression signatures associated with response to AZTIFNα therapy may provide novel insights into the mechanisms of action in ATLL.

Original languageEnglish
Pages (from-to)1200-1216
Number of pages17
JournalLeukemia and Lymphoma
Volume51
Issue number7
DOIs
StatePublished - Jul 1 2010

Fingerprint

Zidovudine
Interferons
T-Lymphocytes
Transcriptome
Antigen Presentation
Genes
cdc Genes
Human T-lymphotropic virus 1
Comparative Genomic Hybridization
Ribosomal Proteins
Therapeutics
Messenger RNA
Neoplasms
Proteins

Keywords

  • Chemotherapeutic approaches
  • lymphoid leukemia
  • prognostication
  • transcription factor changes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Expression profiles of adult T-cell leukemialymphoma and associations with clinical responses to zidovudine and interferon α. / Alizadeh, Ash A.; Bohen, Sean P.; Lossos, Chen; Martinez-Climent, Jose A.; Carlos Ramos, Juan; Cubedo-Gil, Elena; Harrington, William J.; Lossos, Izidore.

In: Leukemia and Lymphoma, Vol. 51, No. 7, 01.07.2010, p. 1200-1216.

Research output: Contribution to journalArticle

Alizadeh, Ash A. ; Bohen, Sean P. ; Lossos, Chen ; Martinez-Climent, Jose A. ; Carlos Ramos, Juan ; Cubedo-Gil, Elena ; Harrington, William J. ; Lossos, Izidore. / Expression profiles of adult T-cell leukemialymphoma and associations with clinical responses to zidovudine and interferon α. In: Leukemia and Lymphoma. 2010 ; Vol. 51, No. 7. pp. 1200-1216.
@article{55096a4b5c524810b5d27dc349519d03,
title = "Expression profiles of adult T-cell leukemialymphoma and associations with clinical responses to zidovudine and interferon α",
abstract = "Adult T-cell leukemialymphoma (ATLL) is an HTLV-1-associated lymphoproliferative malignancy that is frequently fatal. We compared gene expression profiles (GEPs) of leukemic specimens from nine patients with ATLL at the time of diagnosis and immediately after combination therapy with zidovudine (AZT) and interferon α (IFNα). GEPs were also related to genetic aberrations determined by comparative genomic hybridization. We identified several genes anomalously over-expressed in the ATLL leukemic cells at the mRNA level, including LYN, CSPG2, and LMO2, and confirmed LMO2 expression in ATLL cells at the protein level. In vivo AZTIFNα therapy evoked a marked induction of interferon-induced genes accompanied by repression of cell-cycle regulated genes, including those encoding ribosomal proteins. Remarkably, patients not responding to AZTIFNα differed most from responding patients in lower expression of these same IFN-responsive genes, as well as components of the antigen processing and presentation apparatus. Demonstration of specific gene expression signatures associated with response to AZTIFNα therapy may provide novel insights into the mechanisms of action in ATLL.",
keywords = "Chemotherapeutic approaches, lymphoid leukemia, prognostication, transcription factor changes",
author = "Alizadeh, {Ash A.} and Bohen, {Sean P.} and Chen Lossos and Martinez-Climent, {Jose A.} and {Carlos Ramos}, Juan and Elena Cubedo-Gil and Harrington, {William J.} and Izidore Lossos",
year = "2010",
month = "7",
day = "1",
doi = "10.3109/10428191003728628",
language = "English",
volume = "51",
pages = "1200--1216",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Expression profiles of adult T-cell leukemialymphoma and associations with clinical responses to zidovudine and interferon α

AU - Alizadeh, Ash A.

AU - Bohen, Sean P.

AU - Lossos, Chen

AU - Martinez-Climent, Jose A.

AU - Carlos Ramos, Juan

AU - Cubedo-Gil, Elena

AU - Harrington, William J.

AU - Lossos, Izidore

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Adult T-cell leukemialymphoma (ATLL) is an HTLV-1-associated lymphoproliferative malignancy that is frequently fatal. We compared gene expression profiles (GEPs) of leukemic specimens from nine patients with ATLL at the time of diagnosis and immediately after combination therapy with zidovudine (AZT) and interferon α (IFNα). GEPs were also related to genetic aberrations determined by comparative genomic hybridization. We identified several genes anomalously over-expressed in the ATLL leukemic cells at the mRNA level, including LYN, CSPG2, and LMO2, and confirmed LMO2 expression in ATLL cells at the protein level. In vivo AZTIFNα therapy evoked a marked induction of interferon-induced genes accompanied by repression of cell-cycle regulated genes, including those encoding ribosomal proteins. Remarkably, patients not responding to AZTIFNα differed most from responding patients in lower expression of these same IFN-responsive genes, as well as components of the antigen processing and presentation apparatus. Demonstration of specific gene expression signatures associated with response to AZTIFNα therapy may provide novel insights into the mechanisms of action in ATLL.

AB - Adult T-cell leukemialymphoma (ATLL) is an HTLV-1-associated lymphoproliferative malignancy that is frequently fatal. We compared gene expression profiles (GEPs) of leukemic specimens from nine patients with ATLL at the time of diagnosis and immediately after combination therapy with zidovudine (AZT) and interferon α (IFNα). GEPs were also related to genetic aberrations determined by comparative genomic hybridization. We identified several genes anomalously over-expressed in the ATLL leukemic cells at the mRNA level, including LYN, CSPG2, and LMO2, and confirmed LMO2 expression in ATLL cells at the protein level. In vivo AZTIFNα therapy evoked a marked induction of interferon-induced genes accompanied by repression of cell-cycle regulated genes, including those encoding ribosomal proteins. Remarkably, patients not responding to AZTIFNα differed most from responding patients in lower expression of these same IFN-responsive genes, as well as components of the antigen processing and presentation apparatus. Demonstration of specific gene expression signatures associated with response to AZTIFNα therapy may provide novel insights into the mechanisms of action in ATLL.

KW - Chemotherapeutic approaches

KW - lymphoid leukemia

KW - prognostication

KW - transcription factor changes

UR - http://www.scopus.com/inward/record.url?scp=77954092980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954092980&partnerID=8YFLogxK

U2 - 10.3109/10428191003728628

DO - 10.3109/10428191003728628

M3 - Article

VL - 51

SP - 1200

EP - 1216

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 7

ER -